Yang Shi-feng, Xue Wu-jun, Lu Wan-hong, Xie Li-yi, Yin Ai-ping, Zheng Jin, Sun Ji-ping, Li Yang
Department of Nephrology, The First Affiliated Hospital, Medical College, Xi'an Jiaotong University, Xi'an City, Shaanxi Province, China.
Department of Kidney Transplantation, The First Affiliated Hospital, Medical College, Xi'an Jiaotong University, Xi'an City, Shaanxi Province, China.
Transpl Immunol. 2015 Oct;33(2):130-9. doi: 10.1016/j.trim.2015.08.004. Epub 2015 Aug 24.
Syngeneic or autologous hematopoietic stem cells transplantation (HSCT) has been proposed to treat autoimmune diseases because of its immunosuppressive and immunomodulatory effects, which can also contribute to posttransplant antirejection therapy. In this study, we explored the tolerogenic effect of syngeneic HSCT on prolonging islet allograft survival.
C57BL/6 mice received syngeneic HSCT plus preconditioning with sublethal irradiation. Then islets of BALB/c mice were transplanted into the renal subcapsular of C57BL/6 mice after chemically induced into diabetes.
HSCT mice exhibited improved islet allograft survival and increased serum insulin compared to control mice. Islet allografts of HSCT mice displayed lower level lymphocyte infiltration and stronger insulin staining than control mice. T cells of HSCT mice proliferated poorly in response to allogeneic splenocytes compared to control mice. Mice appeared reversed interferon-γ (IFN-γ)/interleukin-4 (IL-4) ratio to a Th2 immune deviation after syngeneic HSCT. The percentage of CD8(+) T cells was lower, while percentage of CD4(+)CD25(+)Foxp3(+) T regulatory cells (Tregs) was higher in HSCT mice than control mice. HSCT mice showed higher percentage of CTLA-4(+) T cells and expression of CTLA-4 mRNA than control mice. Targeting of CTLA-4 by intraperitoneal injection of anti-CTLA-4 mAb abrogated the effect of syngeneic HSCT on prolonging islet allograft survival, inhibiting activity of T cells in response to alloantigen, promoting Th1 to Th2 immune deviation and up regulating CD4(+)CD25(+)Foxp3(+) Tregs.
Syngeneic HSCT plus preconditioning of sublethal irradiation induces tolerance and improves islet allograft survival in fully mismatched mice model. Th1 to Th2 immune deviation, increased CD4(+)CD25(+)Foxp3(+) Tregs and up-regulation of CTLA-4 maybe contribute to the tolerogenic effect induced by syngeneic HSCT.
同基因或自体造血干细胞移植(HSCT)因其免疫抑制和免疫调节作用被提议用于治疗自身免疫性疾病,这也有助于移植后的抗排斥治疗。在本研究中,我们探讨了同基因HSCT对延长胰岛同种异体移植存活时间的致耐受性作用。
C57BL/6小鼠接受同基因HSCT并进行亚致死剂量照射预处理。然后将化学诱导糖尿病后的BALB/c小鼠胰岛移植到C57BL/6小鼠肾被膜下。
与对照小鼠相比,HSCT小鼠的胰岛同种异体移植存活时间延长,血清胰岛素水平升高。HSCT小鼠的胰岛同种异体移植中淋巴细胞浸润水平较低,胰岛素染色比对照小鼠更强。与对照小鼠相比,HSCT小鼠的T细胞对同种异体脾细胞的增殖反应较差。同基因HSCT后,小鼠出现干扰素-γ(IFN-γ)/白细胞介素-4(IL-4)比值逆转,向Th2免疫偏移。HSCT小鼠中CD8(+)T细胞百分比更低,而CD4(+)CD25(+)Foxp3(+)调节性T细胞(Tregs)百分比高于对照小鼠。HSCT小鼠中CTLA-4(+)T细胞百分比和CTLA-4 mRNA表达高于对照小鼠。腹腔注射抗CTLA-4单克隆抗体靶向CTLA-4可消除同基因HSCT对延长胰岛同种异体移植存活时间的作用,抑制T细胞对同种异体抗原的反应活性,促进Th1向Th2免疫偏移并上调CD4(+)CD25(+)Foxp3(+)Tregs。
同基因HSCT加亚致死剂量照射预处理可诱导完全不匹配小鼠模型产生耐受性并改善胰岛同种异体移植存活时间。Th1向Th2免疫偏移、CD4(+)CD25(+)Foxp3(+)Tregs增加以及CTLA-4上调可能有助于同基因HSCT诱导的致耐受性作用。